Pancreatic cancer study tests best radiation dose to extend life
NCT ID NCT04603586
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at 119 people with locally advanced pancreatic cancer to see which radiation dose (lower or higher) works better when combined with chemotherapy. The goal was to find a dose that helps people live longer without causing too many side effects. Participants had not received prior cancer treatment and were in good overall health.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOCALLY ADVANCED PANCREATIC CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Changhai hospital
Shanghai, Shanghai Municipality, 200433, China
-
Shanghai Changhai Hospital
Shanghai, Shanghai Municipality, 200433, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Sleep hormone melatonin put to the test against lupus fatigue and inflammation
- Can early jaw treatment in children prevent major surgery later?
- Brain training may help prevent alcohol relapse after withdrawal
- Should older hepatitis b patients with normal ALT get antivirals? new study explores
- New personalized vaccine takes on tough cancers
- New radiation bead treatment targets Hard-to-Treat pancreatic tumors